Trademark: 97009108
Word
ORYZA PHARMACEUTICALS INC.
Status
Pending
Status Code
760
Status Date
Thursday, February 8, 2024
Serial Number
97009108
Mark Type
4000
Filing Date
Thursday, September 2, 2021

Trademark Owner History

Classifications
5 Pharmaceutical preparations for curing and alleviating various illnesses, namely, hypertension, angina pectoris, heart failure, various conditions accompanied by spasm of smooth muscle, namely, vascular spasm associated with acute myocardial infarction, angina pectoris, peripheral and pulmonary embolism, peripheral vascular disease with a vasospastic element and certain cerebral angiospastic states and visceral spasm, particularly ureteral, biliary or gastrointestinal, and attention deficit hyperactivity disorder; Nutraceuticals for use as a dietary supplement for the treatment of various dietary supplemental needs; Nutraceuticals for use as a dietary supplement
42 Pharmaceutical research and development; Development of pharmaceutical preparations and medicines

Trademark Events
Feb 8, 2024
Ex Parte Appeal-Instituted
Feb 8, 2024
Jurisdiction Restored To Examining Attorney
Feb 8, 2024
Exparte Appeal Received At Ttab
Nov 9, 2023
Application Extension Granted/Receipt Provided
Nov 9, 2023
Application Extension To Response Period - Received
Aug 10, 2023
Notification Of Final Refusal Emailed
Aug 10, 2023
Final Refusal E-Mailed
Aug 10, 2023
Final Refusal Written
Jul 21, 2023
Teas/Email Correspondence Entered
Jul 20, 2023
Correspondence Received In Law Office
Jul 20, 2023
Teas Response To Office Action Received
Apr 14, 2023
Application Extension Granted/Receipt Provided
Apr 14, 2023
Application Extension To Response Period - Received
Jan 22, 2023
Notification Of Non-Final Action E-Mailed
Jan 22, 2023
Non-Final Action E-Mailed
Jan 22, 2023
Non-Final Action Written
Nov 30, 2022
Teas/Email Correspondence Entered
Nov 29, 2022
Correspondence Received In Law Office
Nov 29, 2022
Teas Response To Office Action Received
Jun 3, 2022
Notification Of Non-Final Action E-Mailed
Jun 3, 2022
Non-Final Action E-Mailed
Jun 3, 2022
Non-Final Action Written
May 31, 2022
Assigned To Examiner
Oct 15, 2021
New Application Office Supplied Data Entered
Sep 6, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24